Current Identification of Neoantigens & How this Translates to Preclinical Settings

Time: 12:00 pm
day: Track A - Day 1 AM

Details:

  • Considering the current overview of identification and prioritisation of cancer neoantigens
  • Highlighting the limitations of current neoantigen prediction pipelines
  • Discussing broader challenges associated with cancer neoantigen vaccines

Speakers: